Surmodics - 20 Year Stock Price History | SRDX

Historical daily share prices for Surmodics since 1998 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Surmodics as of August 17, 2018 is 73.45.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.981B $0.073B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.465B 18.95
Abbott Laboratories (ABT) United States $113.540B 23.79
Stryker (SYK) United States $63.571B 24.56
Boston Scientific (BSX) United States $47.586B 24.76
Baxter (BAX) United States $38.489B 26.20
Zimmer Biomet Holdings (ZBH) United States $25.204B 16.19
Smith & Nephew SNATS (SNN) United Kingdom $15.640B 0.00
ResMed (RMD) United States $15.244B 30.25
Perrigo (PRGO) Ireland $9.983B 14.17
Bio-Rad Laboratories (BIO) United States $9.444B 60.64
Canopy Growth (CGC) Canada $7.442B 0.00
Hill-Rom Holdings (HRC) United States $6.341B 21.51
ICU Medical (ICUI) United States $6.026B 40.83
Haemonetics (HAE) United States $5.351B 48.83
Insulet (PODD) United States $5.209B 0.00
Agios Pharmaceuticals (AGIO) United States $4.408B 0.00
Neogen (NEOG) United States $4.354B 69.38
Hutchison China MediTech (HCM) China $3.903B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.778B 0.00
NuVasive (NUVA) United States $3.597B 34.13
National Vision Holdings (EYE) United States $3.054B 67.43
Quidel (QDEL) United States $2.769B 56.74
Phibro Animal Health (PAHC) United States $1.990B 29.55
NxStage Medical (NXTM) United States $1.846B 0.00
Cardiovascular Systems (CSII) United States $1.249B 751.20
Eagle Pharmaceuticals (EGRX) United States $1.176B 34.73
VAREX IMAGING (VREX) United States $1.130B 18.47
AtriCure (ATRC) United States $1.099B 0.00
Orthofix (OFIX) United States $1.017B 30.99
Omeros (OMER) United States $1.016B 0.00
OraSure Technologies (OSUR) United States $1.001B 65.44
Owens & Minor (OMI) United States $0.990B 10.59
TG Therapeutics (TGTX) United States $0.957B 0.00
Cerus (CERS) United States $0.922B 0.00
PetIQ (PETQ) United States $0.847B 29.00
MacroGenics (MGNX) United States $0.845B 0.00
LeMaitre Vascular (LMAT) United States $0.716B 34.34
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.574B 0.00
Evolus (EOLS) United States $0.527B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
NanoString Technologies (NSTG) United States $0.417B 0.00
Cytosorbents (CTSO) United States $0.363B 0.00
BioLife Solutions (BLFS) United States $0.325B 0.00
Utah Medical Products (UTMD) United States $0.324B 20.87
Quanterix (QTRX) United States $0.324B 0.00
Surface Oncology (SURF) United States $0.279B 0.00
Rockwell Medical (RMTI) United States $0.216B 0.00
Chimerix (CMRX) United States $0.195B 0.00
Fonar (FONR) United States $0.170B 10.34
Bovie Medical (BVX) United States $0.161B 0.00
Chembio Diagnostics (CEMI) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.119B 0.00
Female Health (VERU) United States $0.115B 0.00
United-Guardian (UG) United States $0.086B 18.83
Trinity Biotech (TRIB) Ireland $0.085B 25.25
Oramed Pharmaceuticals (ORMP) Israel $0.082B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
InfuSystems Holdings (INFU) United States $0.064B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.064B 0.00
CAS Medical Systems (CASM) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.032B 0.00
Akers Biosciences Inc (AKER) United States $0.025B 0.00
Myomo (MYO) United States $0.024B 0.00
Senestech (SNES) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00